GeneDx Holdings Corp. (WGSWW)

SEC filing

GeneDx Holdings Corp.

WGSWW · CIK 1818331

4 · Sep 18, 2026 · Director, CHIEF EXECUTIVE OFFICER Stueland Katherine sold 10.50K Class A Common Stock at $97.61/unit ($1.0M); exercised options for 37.50K shares

Director, CHIEF EXECUTIVE OFFICER Stueland Katherine sold 10.50K Class A Common Stock at $97.61/unit ($1.0M); exercised options for 37.50K shares

Filed: Sep 18, 2026
Period: Sep 16, 2026
Accession: 0001689575-26-000032
Filer: GeneDx Holdings Corp.

View on SEC.gov All SEC filings

Filing document

xslF345X06/form4-09182026_080912.xml

xslF345X06/form4-09182026_080912.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4form4-09182026_080912.xml
Open SEC.gov